אינטגרילין 2 מגמל

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

EPTIFIBATIDE

Dostupno od:

MERCK SHARP & DOHME (ISRAEL - 1996) COMPANY LTD, ISRAEL

ATC koda:

B01AC16

Farmaceutski oblik:

תמיסה להזרקה

Sastav:

EPTIFIBATIDE 2 MG/ML

Administracija rute:

תוך-ורידי

Tip recepta:

מרשם נדרש

Proizveden od:

SCHERING-PLOUGH LABO. N.V , BELGIUM

Terapijska grupa:

EPTIFIBATIDE

Područje terapije:

EPTIFIBATIDE

Terapijske indikacije:

Integrilin is indicated for the prevention of death and myocardial infarction in patients presenting with high risk unstable angina or non-Q-wave myocardial infarction. Integrilin is indicated in patients who are managed with standard medical therapies and/or with percutaneous coronary intervention. Integrilin is also indicated as an adjunct to percutaneous transluminal coronary angioplasty (PTCA) balloon angioplasty, directional atheretomy, transluminal extraction catheter atherectomy, rotational ablation angioplasty, or excimer laser angioplasty for the prevention of abrupt closure of the treated coronary vessel and related acute ischemic cardiac complications (death, myorardial infarction, need for urgent intervention). Integrilin is intended for use with aspirin and heparin.

Datum autorizacije:

2013-10-31